Combining MR imaging, positron-emission tomography, and CSF biomarkers in the diagnosis and prognosis of Alzheimer disease.

Department of Psychology, CSHC, University of Oslo, Oslo, Norway.
American Journal of Neuroradiology (Impact Factor: 3.68). 02/2010; 31(2):347-54. DOI: 10.3174/ajnr.A1809
Source: PubMed

ABSTRACT Different biomarkers for AD may potentially be complementary in diagnosis and prognosis of AD. Our aim was to combine MR imaging, FDG-PET, and CSF biomarkers in the diagnostic classification and 2-year prognosis of MCI and AD, by examining the following: 1) which measures are most sensitive to diagnostic status, 2) to what extent the methods provide unique information in diagnostic classification, and 3) which measures are most predictive of clinical decline.
ADNI baseline MR imaging, FDG-PET, and CSF data from 42 controls, 73 patients with MCI, and 38 patients with AD; and 2-year clinical follow-up data for 36 controls, 51 patients with MCI, and 25 patients with AD were analyzed. The hippocampus and entorhinal, parahippocampal, retrosplenial, precuneus, inferior parietal, supramarginal, middle temporal, lateral, and medial orbitofrontal cortices were used as regions of interest. CSF variables included Abeta42, t-tau, p-tau, and ratios of t-tau/Abeta42 and p-tau/Abeta42. Regression analyses were performed to determine the sensitivity of measures to diagnostic status as well as 2-year change in CDR-SB, MMSE, and delayed logical memory in MCI.
Hippocampal volume, retrosplenial thickness, and t-tau/Abeta42 uniquely predicted diagnostic group. Change in CDR-SB was best predicted by retrosplenial thickness; MMSE, by retrosplenial metabolism and thickness; and delayed logical memory, by hippocampal volume.
All biomarkers were sensitive to the diagnostic group. Combining MR imaging morphometry and CSF biomarkers improved diagnostic classification (controls versus AD). MR imaging morphometry and PET were largely overlapping in value for discrimination. Baseline MR imaging and PET measures were more predictive of clinical change in MCI than were CSF measures.


Available from: Christine Fennema-Notestine, Apr 25, 2015
  • Source
    [Show abstract] [Hide abstract]
    ABSTRACT: Predicting the change of convert Mild Cognitive Impairment (MCI) to Alzheimer's disease (AD) is an important issue to prevent Alzheimer's disease. This study proposes a new classification method, which is used sparse coding for selecting the useful features of biological markers in the human brain, for improving the accuracy of prediction of the infecting with Alzheimer's disease in MCI subjects. In the proposed method, after features which can improve the accuracy of classification are selected, predicting the infecting with AD will be done by the multi-kernel based learning methods. The empirical results, which applied on MCI subjects' data sets, show that the proposed method significantly improves the accuracy of the prediction of AD in comparison with previous methods.
    National Conference on Information & Communication Technology (ICT'15), Shahid Beheshti University, Tehran, Iran; 02/2015
  • [Show abstract] [Hide abstract]
    ABSTRACT: Recently, there have been great interests for computer-aided diagnosis of Alzheimer’s disease (AD) and its prodromal stage, mild cognitive impairment (MCI). Unlike the previous methods that considered simple low-level features such as gray matter tissue volumes from MRI, and mean signal intensities from PET, in this paper, we propose a deep learning-based latent feature representation with a stacked auto-encoder (SAE). We believe that there exist latent non-linear complicated patterns inherent in the low-level features such as relations among features. Combining the latent information with the original features helps build a robust model in AD/MCI classification, with high diagnostic accuracy. Furthermore, thanks to the unsupervised characteristic of the pre-training in deep learning, we can benefit from the target-unrelated samples to initialize parameters of SAE, thus finding optimal parameters in fine-tuning with the target-related samples, and further enhancing the classification performances across four binary classification problems: AD vs. healthy normal control (HC), MCI vs. HC, AD vs. MCI, and MCI converter (MCI-C) vs. MCI non-converter (MCI-NC). In our experiments on ADNI dataset, we validated the effectiveness of the proposed method, showing the accuracies of 98.8, 90.7, 83.7, and 83.3 % for AD/HC, MCI/HC, AD/MCI, and MCI-C/MCI-NC classification, respectively. We believe that deep learning can shed new light on the neuroimaging data analysis, and our work presented the applicability of this method to brain disease diagnosis.
    Brain Structure and Function 03/2013; 220(2). DOI:10.1007/s00429-013-0687-3 · 4.57 Impact Factor
  • Source
    [Show abstract] [Hide abstract]
    ABSTRACT: In recent years, the diagnosis of Alzheimer’s disease (AD) has become one of the most challenging problems in medical fields. This paper proposes a new classification method which is used sparse coding for selecting the useful properties of biological markers in the human brain for improving the accuracy of diagnosis for AD. In the proposed method, features of collected data sets, which can improve the accuracy of classification, are selected by using sparse coding. Furthermore, the multi-kernel based learning methods are used for diagnosis of AD. The data set will be discussed in this paper contains normal and AD subjects. The empirical results show that the proposed method significantly improves the accuracy of the diagnosis of AD in comparison with previous methods.
    7th Iranian & 1st international conference of Knowledge Management, Shahid Beheshti University, Tehran, Iran; 02/2015